STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $274,000 | +114.1% | 99,397 | +89.0% | 0.09% | +137.8% |
Q4 2020 | $128,000 | +106.5% | 52,597 | +77.3% | 0.04% | +85.0% |
Q3 2020 | $62,000 | +44.2% | 29,667 | +162.8% | 0.02% | +33.3% |
Q2 2020 | $43,000 | -2.3% | 11,287 | -51.5% | 0.02% | -21.1% |
Q1 2020 | $44,000 | – | 23,257 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
&PARTNERS | 15,000 | $28,000 | 0.04% |
Diversified Trust Co | 198,534 | $375,000 | 0.02% |